中国科学院机构知识库网格
Chinese Academy of Sciences Institutional Repositories Grid
首页
机构
成果
学者
登录
注册
登陆
×
验证码:
换一张
忘记密码?
记住我
×
校外用户登录
CAS IR Grid
机构
上海药物研究所 [10]
合肥物质科学研究院 [2]
上海应用物理研究所 [1]
采集方式
OAI收割 [13]
内容类型
期刊论文 [13]
发表日期
2024 [1]
2023 [1]
2022 [1]
2021 [1]
2020 [3]
2019 [1]
更多
学科主题
筛选
浏览/检索结果:
共13条,第1-10条
帮助
条数/页:
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
排序方式:
请选择
提交时间升序
提交时间降序
发表日期升序
发表日期降序
题名升序
题名降序
作者升序
作者降序
The promise and challenges of combination therapies with antibody-drug conjugates in solid tumors
期刊论文
OAI收割
JOURNAL OF HEMATOLOGY & ONCOLOGY, 2024, 卷号: 17, 期号: 1, 页码: 32
作者:
Wei, Qing
;
Li, Peijing
;
Yang, Teng
;
Zhu, Jiayu
;
Sun, Lu
  |  
收藏
  |  
浏览/下载:24/0
  |  
提交时间:2024/02/27
Antibody-drug conjugate
Solid tumor
Combination therapy
Immunotherapy
Targeted therapy
Conjugation site characterization of antibody-drug conjugates using electron-transfer/higher-energy collision dissociation (EThcD)
期刊论文
OAI收割
ANALYTICA CHIMICA ACTA, 2023, 卷号: 1251, 页码: 7
作者:
Song, Yuanli
;
Gao, Jing
;
Meng, Qian
;
Tang, Feng
;
Wang, Yuqiu
  |  
收藏
  |  
浏览/下载:21/0
  |  
提交时间:2023/10/17
Antibody -drug conjugates
EThcD
Conjugation site
Peptide mapping
Quality control
CHMFL-26 is a highly potent irreversible HER2 inhibitor for use in the treatment of HER2-positive and HER2-mutant cancers
期刊论文
OAI收割
ACTA PHARMACOLOGICA SINICA, 2022
作者:
Cao, Jiang-yan
;
Qi, Shuang
;
Wu, Hong
;
Wang, Ao-li
;
Liu, Qing-wang
  |  
收藏
  |  
浏览/下载:53/0
  |  
提交时间:2022/03/28
HER2
breast cancers
gastric cancers
irreversible inhibitor
drug resistance
Cardiotoxicity of Epidermal Growth Factor Receptor 2-Targeted Drugs for Breast Cancer
期刊论文
OAI收割
FRONTIERS IN PHARMACOLOGY, 2021, 卷号: 12
作者:
Yang, ZiYan
;
Wang, Wei
;
Wang, Xiaojia
;
Qin, ZhiQuan
  |  
收藏
  |  
浏览/下载:46/0
  |  
提交时间:2022/01/10
cardiotoxicity
ErbB2
targeting drugs
breast cancer
therapy
An antibody-drug conjugate targeting a GSTA glycosite-signature epitope of MUC1 expressed by non-small cell lung cancer
期刊论文
OAI收割
CANCER MEDICINE, 2020, 页码: 12
作者:
Pan, Deng
;
Tang, Yubo
;
Tong, Jiao
;
Xie, Chengmei
;
Chen, Jiaxi
  |  
收藏
  |  
浏览/下载:33/0
  |  
提交时间:2020/12/24
YES1amplification confers trastuzumab-emtansine (T-DM1) resistance in HER2-positive cancer
期刊论文
OAI收割
BRITISH JOURNAL OF CANCER, 2020, 页码: 12
作者:
Wang, Lei
;
Wang, Quanren
;
Xu, Piaopiao
;
Fu, Li
;
Li, Yun
  |  
收藏
  |  
浏览/下载:18/0
  |  
提交时间:2020/12/24
DNA Origami-Enabled Engineering of Ligand-Drug Conjugates for Targeted Drug Delivery
期刊论文
OAI收割
SMALL, 2020, 卷号: 16, 期号: 16, 页码: -
作者:
Ge, ZL
;
Guo, LJ
;
Wu, GQ
;
Li, J
;
Sun, YL
  |  
收藏
  |  
浏览/下载:31/0
  |  
提交时间:2021/09/06
TRASTUZUMAB EMTANSINE
BRENTUXIMAB VEDOTIN
CANCER-THERAPY
ANTIBODY
NANOSTRUCTURES
NANOROBOT
TRANSPORT
EFFICACY
IMPROVES
SYSTEM
Safety, Efficacy, and Biomarker Analysis of Pyrotinib in Combination with Capecitabine in HER2-Positive Metastatic Breast Cancer Patients: A Phase I Clinical Trial
期刊论文
OAI收割
CLINICAL CANCER RESEARCH, 2019, 卷号: 25, 期号: 17, 页码: 5212-5220
作者:
Li, Qiao
;
Guan, Xiuwen
;
Chen, Shanshan
;
Yi, Zongbi
;
Lan, Bo
  |  
收藏
  |  
浏览/下载:26/0
  |  
提交时间:2020/07/01
STAT3 activation confers trastuzumab-emtansine (T-DM1) resistance in HER2-positive breast cancer
期刊论文
OAI收割
CANCER SCIENCE, 2018, 卷号: 109, 期号: 10, 页码: 3305-3315
作者:
Wang, Lei
;
Wang, Quanren
;
Gao, Mingzhao
;
Fu, Li
;
Li, Yun
  |  
收藏
  |  
浏览/下载:50/0
  |  
提交时间:2019/01/08
drug resistance
leukemia inhibitory factor receptor
secreted factor
STAT3
trastuzumab-emtansine
Current Strategies and Applications for Precision Drug Design
期刊论文
OAI收割
FRONTIERS IN PHARMACOLOGY, 2018, 卷号: 9
作者:
Wang, Chen
;
Xu, Pan
;
Zhang, Luyu
;
Huang, Jing
;
Zhu, Kongkai
  |  
收藏
  |  
浏览/下载:47/0
  |  
提交时间:2019/01/08
precision medicine
precision drug design
computational modeling
deep learning
antibody-drug conjugates
ligand-targeted conjugates